<code id='A3A6383534'></code><style id='A3A6383534'></style>
    • <acronym id='A3A6383534'></acronym>
      <center id='A3A6383534'><center id='A3A6383534'><tfoot id='A3A6383534'></tfoot></center><abbr id='A3A6383534'><dir id='A3A6383534'><tfoot id='A3A6383534'></tfoot><noframes id='A3A6383534'>

    • <optgroup id='A3A6383534'><strike id='A3A6383534'><sup id='A3A6383534'></sup></strike><code id='A3A6383534'></code></optgroup>
        1. <b id='A3A6383534'><label id='A3A6383534'><select id='A3A6383534'><dt id='A3A6383534'><span id='A3A6383534'></span></dt></select></label></b><u id='A3A6383534'></u>
          <i id='A3A6383534'><strike id='A3A6383534'><tt id='A3A6383534'><pre id='A3A6383534'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:6
          Richard Neal. -- health policy coverage from STAT
          Rep. Richard Neal (D-Mass.) Drew Angerer/Getty Images

          WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display in the House on Wednesday.

          Republicans on the House Ways & Means Committee introduced a package this week that they say would increase health care transparency, but Democrats and outside groups are arguing that it doesn’t go far enough to force companies to disclose information about their ownership. They also think it goes too easy on the private equity firms that are buying up health care practices.

          advertisement

          “There was an opportunity here for bipartisanship, but I think we ought to reference that in the past tense,” said ranking Democrat Richard Neal (D-Mass.).

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Grail spinoff by Illumina should end disastrous merger attempt
          Grail spinoff by Illumina should end disastrous merger attempt

          AdobeIllumina,theleadingmakerofDNAsequencingmachines,saidSundaythatitwoulddivestGrail,thedeveloperof

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          FDA official pushes for dedicated emerging pathogens team

          PeterMarks,directoroftheFDA'sCenterforBiologicsEvaluationandResearchGregNash/PoolviaAPWASHINGTON—Ato